School of Medicine
Showing 321-340 of 1,584 Results
-
Ifeanyichukwu Emmanuel Eke
Postdoctoral Scholar, Pathology
BioI am a chemical biologist with a broad interest in defining the mechanisms-of-action of novel compounds that can be used as potential drugs or diagnostic probes for different bacterial and viral infections. In addition to my flair for research, I am passionate about teaching, mentorship, leadership, and entrepreneurship.
-
Ahmet Görkem Er
Postdoctoral Scholar, Radiology
BioAhmet Görkem Er, M.D., Ph.D., is a physician-scientist and postdoctoral fellow in Integrative Biomedical Imaging Informatics (IBIIS) at Stanford University. He graduated from Istanbul University Faculty of Medicine and completed dual residency training in internal medicine and infectious diseases and clinical microbiology at Hacettepe University. He also has a Ph.D. in medical informatics from Middle East Technical University.
As a Fulbright Ph.D. Dissertation Research Grantee (2022–2023), Dr. Er conducted research at the Stanford Center for Biomedical Informatics Research, focusing on multimodal data integration in COVID-19 patients. This work resulted in a publication in NPJ Digital Medicine demonstrating the value of combining clinical, imaging, and viral genomic data for improved disease modeling. He returned to Stanford in 2024 as a visiting researcher and is currently a postdoctoral fellow, where he combines his clinical background with advanced computational methods.
Dr. Er’s research focuses on developing artificial intelligence and multimodal data fusion approaches for complex diseases. His work integrates a broad spectrum of inputs, including medical imaging, histopathology, clinical data, genomics, and spatial transcriptomics, to improve patient stratification and support data-driven clinical decision-making. -
Ali Etemadi
Postdoctoral Scholar, Nephrology
Current Research and Scholarly InterestsI am a clinician and data scientist focusing on drawing causal inferences from observational data when randomized controlled trials are not feasible. Currently, my work centers on patients with late-stage chronic kidney disease, a rapidly growing population for which evidence is limited due to their frequent exclusion from RCTs. At the moment, I aim to move towards precision medicine approaches to optimize outcomes for these patients.
